Abstract
Research has yielded important insights into the impact of radical prostatectomy in patients with localized prostate cancer. Other recent research has focused on the role of nutrition in prostate cancer development and progression, improved prognostication for patients with both early and advanced prostate cancer, efficacy of adjuvant and neoadjuvant hormonal therapy, and development of novel agents. In addition, the role of bisphosphonates in patients with bone metastasis was established.
MeSH terms
-
Aged
-
Androgen Antagonists / administration & dosage
-
Clinical Trials as Topic
-
Combined Modality Therapy
-
Diphosphonates / administration & dosage
-
Humans
-
Male
-
Middle Aged
-
Neoplasm Staging
-
Prognosis
-
Prostate-Specific Antigen / blood*
-
Prostatectomy / methods
-
Prostatic Neoplasms / mortality
-
Prostatic Neoplasms / pathology*
-
Prostatic Neoplasms / therapy*
-
Radiotherapy / methods
-
Risk Assessment
-
Survival Analysis
-
Treatment Outcome
Substances
-
Androgen Antagonists
-
Diphosphonates
-
Prostate-Specific Antigen